
Clocapramine dihydrochloride hydrate
CAS No. 60789-62-0
Clocapramine dihydrochloride hydrate ( —— )
产品货号. M26121 CAS No. 60789-62-0
Clocapramine Hydrochronic Hydrate 是 5-HT2A 和 D2 受体的拮抗剂。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥9072 | 有现货 |
![]() ![]() |
10MG | ¥12069 | 有现货 |
![]() ![]() |
25MG | ¥18063 | 有现货 |
![]() ![]() |
50MG | ¥23976 | 有现货 |
![]() ![]() |
100MG | ¥32157 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Clocapramine dihydrochloride hydrate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Clocapramine Hydrochronic Hydrate 是 5-HT2A 和 D2 受体的拮抗剂。
-
产品描述Clocapramine hydrochloride hydrate is an antagonist of the 5-HT2A and D2 receptors.(In Vivo):Clocapramine shows the lowest potency for D2-occupancy in vivo . An in vivo receptor binding technique is used to evaluate the binding profiles of typical and atypical antipsychotic drugs to striatal dopamine-D2 and frontal serotonin-5-HT2 receptors in a rat brain using more specific ligands. Clocapramine produces ratios of potency in occupying 5-HT2 versus D2 receptors that fall between these two groups (ED50s: 14.5 mg/kg for D2, 4.9 mg/kg for 5-HT2) .
-
体外实验——
-
体内实验Clocapramine shows the lowest potency for D2-occupancy in vivo. An in vivo receptor binding technique is used to evaluate the binding profiles of typical and atypical antipsychotic drugs to striatal dopamine-D2 and frontal serotonin-5-HT2 receptors in a rat brain using more specific ligands. Clocapramine produces ratios of potency in occupying 5-HT2 versus D2 receptors that fall between these two groups (ED50 of 14.5 mg/kg for D2, 4.9 mg/kg for 5-HT2).
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Wnt
-
研究领域——
-
适应症——
化学信息
-
CAS Number60789-62-0
-
分子量572.01
-
分子式C28H41Cl3N4O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO.Cl.Cl.NC(=O)C1(CCN(CCCN2c3ccccc3CCc3ccc(Cl)cc23)CC1)N1CCCCC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Charlene F. Barroga, et al. Diketones and hydroxyketones as catenin signaling pathway activators. WO2012024404A1.
产品手册




关联产品
-
Hyaluronic acid
透明质酸是一种葡萄糖胺聚糖,由 D-葡萄糖醛酸和 N-乙酰基-D-葡萄糖胺二糖单元组成。
-
Halofuginone hydrobr...
Halofuginone 特异性抑制 I 型胶原蛋白基因表达和基质金属蛋白酶 2 (MMP-2) 基因表达,从而抑制血管生成、肿瘤基质细胞发育和肿瘤细胞生长。
-
Meticrane
Meticrane 是一种利尿剂。Meticrane 抑制远曲小管中钠离子和氯离子的重吸收。Meticrane 可于研究原发性高血压。